China's COVID-19 vaccine development enters phase II

A COVID-19 vaccine research group is recruiting 500 more volunteers for phase two clinical trials. Volunteers will have a 50 percent chance of getting a medium dose injection, a 25 percent of getting a low dose injection, and a 25 percent chance of getting a placebo. High-doses are excluded as phase one test results show it is more likely to cause a temporary fever.

Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv

Follow us on:
Website: https://www.cgtn.com/
Facebook: https://www.facebook.com/ChinaGlobalTVNetwork/
Twitter: https://twitter.com/CGTNOfficial
Instagram: https://www.instagram.com/cgtn/?hl=zh-cn
Pinterest: https://www.pinterest.com/CGTNOfficial/
Weibo: http://weibo.com/cctvnewsbeijing
Douyin: http://v.douyin.com/aBbmNQ/